Status:
COMPLETED
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Lead Sponsor:
Hospital Britanico
Conditions:
IGA Nephropathy
Eligibility:
All Genders
21-70 years
Phase:
PHASE4
Brief Summary
TO ASSESS THE EFFICACY OF THE RENIN ANGIOTENSIN SYSTEM PLUS STEROIDS TO DECREASE THE AMOUNT OF PROTEINURIA IN IGA NEPHROPATHY
Detailed Description
Patients whose proteinuria was \> 0.5 g/day were to receive enalapril plus valsartan coupled with oral 0.5 g/day of methylprednisone for 6 months.
Eligibility Criteria
Inclusion
- PATIENTES WITH IGA NEPHROPATHY WITH PROTEINURIA OVER 0.5 G/DAY
Exclusion
- MALIGNANCY, RENAL FAILURE
Key Trial Info
Start Date :
January 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00367562
Start Date
January 1 1996
End Date
December 1 2005
Last Update
November 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Britanico de Buenos Aires
Buenos Aires, Buenos Aires, Argentina, 1280